Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 60 years old
- People who have been diagnosed with pulmonary hypertension (high blood pressure in the lungs), confirmed by a right heart catheterization test showing specific pressure and resistance readings
- People with one of three specific types of pulmonary hypertension: Arterial Pulmonary Hypertension (PAH), pulmonary hypertension linked to lung disease, or Chronic Thromboembolic Pulmonary Hypertension (CTEPH), as classified by the World Health Organization
- People who have not experienced fainting or warning signs of fainting during walking or physical activity
- People who have not had serious heart rhythm problems during rest or exercise, such as certain dangerous irregular heartbeats or significant heart conduction problems
- People whose medications and medication routine have been stable for at least 3 months before joining, and who have not taken part in any organised exercise training program for at least 3 months before screening
- People who are comfortable and capable using smartphones and monitoring devices
- People who are willing to sign a consent form agreeing to take part
Who may not be able to join:
- People who also have venous thromboembolism (blood clots in the veins)
- People who have had a recent acute pulmonary embolism (a sudden blood clot in the lungs)
- People who experience chest pain or can only manage very low levels of physical activity (below 3 METs) during exercise or recovery (confirm with trial site)
- People whose blood pressure or heart rhythm responds abnormally during exercise
- People with severe mental health or cognitive (thinking and memory) conditions
- People who are unable to exercise due to neurological (nervous system) or musculoskeletal (muscle or bone) problems
- People with CTEPH who are planned to have a lung artery procedure or surgery within the next 6 months
- People who have other serious ongoing illnesses, such as cancer, tuberculosis, an overactive thyroid, or severe depression
- People who are pregnant
- People who do not wish to sign the consent form
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 88396992
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
changes in 6MWD after 3 months; changes in muscle mass after 3 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.